Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Cell Surface Protein Detection to Assess Receptor Internalization.

Czarnecka M, Kitlinska J.

Bio Protoc. 2016 Oct 20;6(20). pii: e1968. doi: 10.21769/BioProtoc.1968.

2.

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis.

Hong SH, Tilan JU, Galli S, Acree R, Connors K, Mahajan A, Wietlisbach L, Polk T, Izycka-Swieszewska E, Lee YC, Cavalli LR, Rodriguez OC, Albanese C, Kitlinska JB.

J Vis Exp. 2016 Dec 9;(118). doi: 10.3791/54532.

3.

Neuropeptide Y as a Biomarker and Therapeutic Target for Neuroblastoma.

Galli S, Naranjo A, Van Ryn C, Tilan JU, Trinh E, Yang C, Tsuei J, Hong SH, Wang H, Izycka-Swieszewska E, Lee YC, Rodriguez OC, Albanese C, Kitlinska J.

Am J Pathol. 2016 Nov;186(11):3040-3053. doi: 10.1016/j.ajpath.2016.07.019. Epub 2016 Oct 12.

4.

Influence of paternal preconception exposures on their offspring: through epigenetics to phenotype.

Day J, Savani S, Krempley BD, Nguyen M, Kitlinska JB.

Am J Stem Cells. 2016 May 15;5(1):11-8. eCollection 2016. Review.

5.

Neuropeptide Y (NPY) in tumor growth and progression: Lessons learned from pediatric oncology.

Tilan J, Kitlinska J.

Neuropeptides. 2016 Feb;55:55-66. doi: 10.1016/j.npep.2015.10.005. Epub 2015 Oct 26. Review.

6.

Elevated levels of neuropeptide Y in preeclampsia: A pilot study implicating a role for stress in pathogenesis of the disease.

Paiva SP, Veloso CA, Campos FF, Carneiro MM, Tilan JU, Wang H, Umans JG, Zukowska Z, Kitlinska J.

Neuropeptides. 2016 Feb;55:127-35. doi: 10.1016/j.npep.2015.09.006. Epub 2015 Sep 25.

7.

High neuropeptide Y release associates with Ewing sarcoma bone dissemination - in vivo model of site-specific metastases.

Hong SH, Tilan JU, Galli S, Izycka-Swieszewska E, Polk T, Horton M, Mahajan A, Christian D, Jenkins S, Acree R, Connors K, Ledo P, Lu C, Lee YC, Rodriguez O, Toretsky JA, Albanese C, Kitlinska J.

Oncotarget. 2015 Mar 30;6(9):7151-65.

8.

Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma--associations with tumor phenotype and survival.

Tilan JU, Krailo M, Barkauskas DA, Galli S, Mtaweh H, Long J, Wang H, Hawkins K, Lu C, Jeha D, Izycka-Swieszewska E, Lawlor ER, Toretsky JA, Kitlinska JB.

Cancer. 2015 Mar 1;121(5):697-707. doi: 10.1002/cncr.29090. Epub 2014 Nov 11.

9.

Neuropeptide Y receptor Y5 as an inducible pro-survival factor in neuroblastoma: implications for tumor chemoresistance.

Czarnecka M, Trinh E, Lu C, Kuan-Celarier A, Galli S, Hong SH, Tilan JU, Talisman N, Izycka-Swieszewska E, Tsuei J, Yang C, Martin S, Horton M, Christian D, Everhart L, Maheswaran I, Kitlinska J.

Oncogene. 2015 Jun 11;34(24):3131-43. doi: 10.1038/onc.2014.253. Epub 2014 Aug 18.

10.

Hypoxia shifts activity of neuropeptide Y in Ewing sarcoma from growth-inhibitory to growth-promoting effects.

Tilan JU, Lu C, Galli S, Izycka-Swieszewska E, Earnest JP, Shabbir A, Everhart LM, Wang S, Martin S, Horton M, Mahajan A, Christian D, O'Neill A, Wang H, Zhuang T, Czarnecka M, Johnson MD, Toretsky JA, Kitlinska J.

Oncotarget. 2013 Dec;4(12):2487-501.

11.

Platelet neuropeptide Y is critical for ischemic revascularization in mice.

Tilan JU, Everhart LM, Abe K, Kuo-Bonde L, Chalothorn D, Kitlinska J, Burnett MS, Epstein SE, Faber JE, Zukowska Z.

FASEB J. 2013 Jun;27(6):2244-55. doi: 10.1096/fj.12-213546. Epub 2013 Mar 1.

12.

Stress hormone epinephrine enhances adipogenesis in murine embryonic stem cells by up-regulating the neuropeptide Y system.

Han R, Kitlinska JB, Munday WR, Gallicano GI, Zukowska Z.

PLoS One. 2012;7(5):e36609. doi: 10.1371/journal.pone.0036609. Epub 2012 May 3.

13.

Maternal low-protein diet up-regulates the neuropeptide Y system in visceral fat and leads to abdominal obesity and glucose intolerance in a sex- and time-specific manner.

Han R, Li A, Li L, Kitlinska JB, Zukowska Z.

FASEB J. 2012 Aug;26(8):3528-36. doi: 10.1096/fj.12-203943. Epub 2012 Apr 25.

14.

Dipeptidyl peptidases as survival factors in Ewing sarcoma family of tumors: implications for tumor biology and therapy.

Lu C, Tilan JU, Everhart L, Czarnecka M, Soldin SJ, Mendu DR, Jeha D, Hanafy J, Lee CK, Sun J, Izycka-Swieszewska E, Toretsky JA, Kitlinska J.

J Biol Chem. 2011 Aug 5;286(31):27494-505. doi: 10.1074/jbc.M111.224089. Epub 2011 Jun 16.

15.

Of mice and men: neuropeptide Y and its receptors are associated with atherosclerotic lesion burden and vulnerability.

Li L, Najafi AH, Kitlinska JB, Neville R, Laredo J, Epstein SE, Burnett MS, Zukowska Z.

J Cardiovasc Transl Res. 2011 Jun;4(3):351-62. doi: 10.1007/s12265-011-9271-5. Epub 2011 Apr 6.

PMID:
21468772
16.

Neuropeptide Y and its Y2 receptor: potential targets in neuroblastoma therapy.

Lu C, Everhart L, Tilan J, Kuo L, Sun CC, Munivenkatappa RB, Jönsson-Rylander AC, Sun J, Kuan-Celarier A, Li L, Abe K, Zukowska Z, Toretsky JA, Kitlinska J.

Oncogene. 2010 Oct 14;29(41):5630-42. doi: 10.1038/onc.2010.301. Epub 2010 Aug 2.

17.

Sympathetic Neurotransmitters and Tumor Angiogenesis-Link between Stress and Cancer Progression.

Tilan J, Kitlinska J.

J Oncol. 2010;2010:539706. doi: 10.1155/2010/539706. Epub 2010 May 20.

18.

Chronic stress, combined with a high-fat/high-sugar diet, shifts sympathetic signaling toward neuropeptide Y and leads to obesity and the metabolic syndrome.

Kuo LE, Czarnecka M, Kitlinska JB, Tilan JU, Kvetnanský R, Zukowska Z.

Ann N Y Acad Sci. 2008 Dec;1148:232-7. doi: 10.1196/annals.1410.035.

19.

Interactions of multiple signaling pathways in neuropeptide Y-mediated bimodal vascular smooth muscle cell growth.

Pons J, Kitlinska J, Jacques D, Perreault C, Nader M, Everhart L, Zhang Y, Zukowska Z.

Can J Physiol Pharmacol. 2008 Jul;86(7):438-48. doi: 10.1139/y08-054.

20.

Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome.

Kuo LE, Kitlinska JB, Tilan JU, Li L, Baker SB, Johnson MD, Lee EW, Burnett MS, Fricke ST, Kvetnansky R, Herzog H, Zukowska Z.

Nat Med. 2007 Jul;13(7):803-11. Epub 2007 Jul 1. Erratum in: Nat Med. 2007 Sep;13(9):1120.

PMID:
17603492
21.

Neuropeptide Y (NPY) in neuroblastoma: effect on growth and vascularization.

Kitlinska J.

Peptides. 2007 Feb;28(2):405-12. Epub 2007 Jan 16. Review.

PMID:
17229489
22.

Role of neuropeptide Y and dipeptidyl peptidase IV in regulation of Ewing's sarcoma growth.

Kitlinska J, Kuo L, Abe K, Pons J, Yu M, Li L, Tilan J, Toretsky J, Zukowska Z.

Adv Exp Med Biol. 2006;575:223-9. Review. No abstract available.

PMID:
16700526
23.

Neuropeptide Y in neural crest-derived tumors: effect on growth and vascularization.

Kitlinska J.

Cancer Lett. 2007 Jan 8;245(1-2):293-302. Epub 2006 Mar 2. Review.

PMID:
16513255
24.

Differential effects of neuropeptide Y on the growth and vascularization of neural crest-derived tumors.

Kitlinska J, Abe K, Kuo L, Pons J, Yu M, Li L, Tilan J, Everhart L, Lee EW, Zukowska Z, Toretsky JA.

Cancer Res. 2005 Mar 1;65(5):1719-28.

25.

Neuropeptide Y: multiple receptors and multiple roles in cardiovascular diseases.

Pons J, Lee EW, Li L, Kitlinska J.

Curr Opin Investig Drugs. 2004 Sep;5(9):957-62. Review.

PMID:
15503651
26.

Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles.

Lee EW, Michalkiewicz M, Kitlinska J, Kalezic I, Switalska H, Yoo P, Sangkharat A, Ji H, Li L, Michalkiewicz T, Ljubisavljevic M, Johansson H, Grant DS, Zukowska Z.

J Clin Invest. 2003 Jun;111(12):1853-62.

27.

Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system.

Pons J, Kitlinska J, Ji H, Lee EW, Zukowska Z.

Can J Physiol Pharmacol. 2003 Feb;81(2):177-85.

PMID:
12710532
28.

Dual role of dipeptidyl peptidase IV (DPP IV) in angiogenesis and vascular remodeling.

Kitlinska J, Lee EW, Li L, Pons J, Estes L, Zukowska Z.

Adv Exp Med Biol. 2003;524:215-22. No abstract available.

PMID:
12675242
29.

Neuropeptide Y-induced angiogenesis in aging.

Kitlinska J, Lee EW, Movafagh S, Pons J, Zukowska Z.

Peptides. 2002 Jan;23(1):71-7.

PMID:
11814620
30.

Rb1 gene expression in B-cell lymphocytic leukaemia cases with deletion in the 13q14 region.

Antosz H, Kitlińska J, Kwiatkowska-Drabik B, Koczkodaj D, Wach M, Antosz M, Rudzki S, Wojcierowski J.

Cytobios. 1997;92(369):111-21.

PMID:
9693880
31.

[Gene K-ras mutation in cells of endometrial adenocarcinoma in women].

Semczuk A, Wojcierowski J, Kitlińska J, Kotarski J, Rózańska K.

Ginekol Pol. 1996 May;67(5):259-63. Polish.

PMID:
8925998
32.

RNA isolation from solid tumor tissue.

Kitlińska J, Wojcierowski J.

Anal Biochem. 1995 Jun 10;228(1):170-2. No abstract available.

PMID:
8572276

Supplemental Content

Loading ...
Support Center